This is the authors' abstract. We don't add key points for this paper.
Analysis of 9-year cotest results from a national reference laboratory confirms the value of LBC element in cotesting. This supports that LBC/HPV cotesting enhances screening for the identification of CxCa in women 30 years and older, more so than LBC or HPV alone within cotesting.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kaufman et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: